After 20 years, Canada’s Supreme Court has finally made a decision on the GlaxoSmithKline case. The litigation is not yet over, however. Dale Hill, Mark Kirkey & Pierre Alary of Gowlings – Taxand explain why.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Two months since EU political agreement on pillar two and few member states have made progress on new national laws, but the arrival of OECD technical guidance should quicken the pace. Ralph Cunningham reports.